000 | 01109 a2200313 4500 | ||
---|---|---|---|
005 | 20250513045325.0 | ||
264 | 0 | _c19950308 | |
008 | 199503s 0 0 ger d | ||
022 | _a0340-9937 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aSpiecker, M | |
245 | 0 | 0 |
_a[Pro-urokinase for infarct therapy]. _h[electronic resource] |
260 |
_bHerz _cDec 1994 |
||
300 |
_a326-35 p. _bdigital |
||
500 | _aPublication Type: Comparative Study; Journal Article; Review | ||
650 | 0 | 4 |
_aAnticoagulants _xadministration & dosage |
650 | 0 | 4 | _aDose-Response Relationship, Drug |
650 | 0 | 4 | _aDrug Therapy, Combination |
650 | 0 | 4 | _aHospital Mortality |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aMyocardial Infarction _xdrug therapy |
650 | 0 | 4 | _aRandomized Controlled Trials as Topic |
650 | 0 | 4 |
_aRecombinant Proteins _xadministration & dosage |
650 | 0 | 4 |
_aThrombolytic Therapy _xmethods |
650 | 0 | 4 |
_aTissue Plasminogen Activator _xadministration & dosage |
650 | 0 | 4 |
_aUrokinase-Type Plasminogen Activator _xadministration & dosage |
700 | 1 | _aMeyer, J | |
773 | 0 |
_tHerz _gvol. 19 _gno. 6 _gp. 326-35 |
|
999 |
_c7843027 _d7843027 |